Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company, announced that the United States Food and Drug Administration (FDA) has given approval to the Company to market its original CONSERVE® Plus Total Hip Resurfacing System.

Original post: 
Wright Medical Group, Inc. Receives FDA Approval To Market CONSERVE(R) Plus Total Hip Resurfacing System

Related posts:

1. Amneal Receives FDA Approval For Nizatidine Oral Solution, The First Generic Oral Solution For Axid(R) In The MarketAmneal Pharmaceuticals is pleased to announce that it has received U.S. FDA approval to manufacture Nizatidine Oral Solution in the 15 mg/mL strength effective November 18, 2009. It is an...
2. SafeStitch Medical, Inc. Receives FDA Clearance To Market The AMID StaplerTM For Hernia RepairsSafeStitch Medical, Inc. (OTCBB:SFES) announced that it has received 510(k) clearance from the U.S. Food and Drug Administration ("FDA") to market its AMID StaplerTM in the U.S. with the intended...
3. Pfizer Receives FDA Approval For Geodon(R) (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In AdultsPfizer announced that the U.S. Food and Drug Administration (FDA) has approved Geodon® (ziprasidone HCI) Capsules for maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate...
4. Mylan Receives Tentative FDA Approval Under PEPFAR For Matrix Laboratories’ New Drug Application (NDA) For Efavirenz TabletsMylan Inc. (Nasdaq: MYL) announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS...
5. Tripep Receives Approval For Expanding The ChronVac-C(R) Study With One More VaccinationTripep (STO:TPEP) received the approval from the Swedish Medical Products Agency and the local ethical committee to give three patients in the highest dose group in the ChronVac-C® study one...
6. Mylan Receives Approval For Generic Version Of Antiepileptic Keppra® 1000 MgMylan Inc. (NASDAQ: MYL) announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for...
7. DGIMED Receives FDA Clearance On IM Nail SystemDGIMED ORTHO, Inc. announced that the company has received notification of clearance on its 510(k) submission for the Company's proprietary Drill and Intramedullary (IM) Nail system. "This timely notification keeps...
8. Santarus Announces FDA Approval Of Schering-Plough HealthCare Products’ ZEGERID OTCSantarus, Inc. (NASDAQ: SNTS), a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Schering-Plough HealthCare Products, Inc.'s, New Drug Application (NDA) for ZEGERID...
9. The Medicines Company Receives European Approval For Angiox(R) (Bivalirudin) For Use In Heart Attack Patients Undergoing Emergency Heart ProceduresThe Medicines Company (NASDAQ: MDCO) announced today that it has received European approval for the use of Angiox® (bivalirudin) as an anticoagulant in patients with heart attacks (so-called ST-segment elevation...
10. Neuralstem Receives Approval To Commence First ALS Stem Cell Trial At Emory ALS CenterNeuralstem, Inc. (NYSE Amex: CUR) announced that its Phase I trial to treat Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) with its spinal cord stem cells has been approved...
11. Gore Receives European CE Mark Approval For Next Generation Conformable GORE TAG(R) Thoracic EndoprosthesisW.L. Gore & Associates (Gore) announced that it has received European CE Mark approval for the next generation GORE TAG® Thoracic Endoprosthesis. ...
12. Dendreon Receives FDA Acknowledgement Of Complete ResponseDendreon Corporation (Nasdaq: DNDN) announced that the U.S. Food and Drug Administration (FDA) provided written acknowledgement that the Company's amended Biologics License Application (BLA) for PROVENGE® (sipuleucel-T) is a complete...
13. Lannett Receives FDA Approvals For Hydromorphone Hydrochloride Tablets USP, 2 Mg, 4 Mg And 8 Mg StrengthsLannett Company, Inc. (NYSE AMEX: LCI) announced that it has received approvals from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Applications (ANDAs) for Hydromorphone Hydrochloride...
14. Novartis Receives Regulatory Approval In Germany For Celtura®, A Cell Culture-based Influenza A(H1N1) Pandemic VaccineNovartis announced that it received approval from the German regulatory authorities for its adjuvanted cell culture-based Influenza A(H1N1) 2009 monovalent vaccine, Celtura®. Novartis continues to pursue registration in other major...
15. GenSpera Receives Approval To Commence G-202 Phase I Trial At The University Of Wisconsin Carbone Cancer CenterGenSpera, Inc. (OTCBB: GNSZ) announced that the Institutional Review Board (IRB) at the University of Wisconsin, in Madison, WI, has approved a Phase I study of its target activated pro-drug,...